GlaxoSmithKline Pharmaceuticals Limited
Quant Mutual Fund disclosed a new 1.01% stake in GlaxoSmithKline Pharmaceuticals Limited. The mutual fund holds 17,11,332 shares, crossing the 1% public disclosure threshold.
A leading pharmaceutical company, GlaxoSmithKline Pharmaceuticals researches, manufactures, and distributes a broad range of medicines and vaccines across India and internationally. The company operates across multiple therapeutic areas including respiratory, oncology, dermatology, and vaccines, serving healthcare providers and patients. Its integrated operations span drug development, manufacturing, quality assurance, and distribution networks throughout the country and beyond.
Built a quantitative, data-driven investment philosophy in an industry dominated by discretionary stock pickers. Manages over Rs 1.2 lakh crore. Founded by Sanjeev Sharma, Quant MF uses VLRT (Valuation, Liquidity, Risk, and Time) framework to run high-turnover, tactically active portfolios. Grew from obscurity to one of India's top-15 AMCs in under five years, attracting both retail capital and scrutiny for its aggressive churn.